News
FDA Shuts Down Sarepta Gene Therapy Trials
Digest more
A Food and Drug Administration expert panel has reignited a debate over whether hormone therapy should be used to treat ...
Mushrooms sold across two states have been recalled over fears they could be harboring listeria, a bug that "can cause ...
Pharmalittle: We’re reading about Sarepta conceding to the FDA, the U.S. transplant system, and more
Sarepta Therapeutics reversed course and agreed to halt all shipments of Elevidys, its gene therapy for Duchenne muscular ...
Prefilled syringe eliminates the need to reconstitute separate vials prior to administration and simplifies the vaccine ...
The FDA granted an orphan drug designation to novel hedgehog pathway inhibitor taladegib, also known as ENV-101, for treating ...
“Dr. Tidmarsh is an accomplished physician-scientist and leader whose experience spans the full arc of drug development — ...
Explore more
Sarepta Therapeutics shares were lower in premarket trading on Tuesday, as the drugmaker relented to a Food and Drug ...
It's a good thing the U.S. Food and Drug Administration is staying on top of the latest recalls, because knowing about new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results